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1. Introduction
Osseous tissue forms in various 
physiologi cal circumstances, ranging from 
normal bone development and callus-
mediated fracture repair, to pathological 
heterotopic bone formation in extra-skel-
etal tissues, as seen following muscle 
trauma, traumatic brain and spinal cord 
injury, surgical procedures of the hip and 
knee; and in genetic conditions such as 
fibrodysplasia ossificans progressiva (FOP).[1–9] 
These contexts, normal or otherwise, share 
fundamental characteristics at many levels, 
including molecular (overexpression of 
bone morphogenic proteins, BMPs), cel-
lular (a set of progenitor cells that commits 
to an osteoblastic lineage) and biomechan-
ical (translation of the mechanical forces 
into structured and organized bone).[3,10–15] 
However, there are still significant gaps 
in our understanding of these events and 
in particular few models allow long-term 
Bone is a dynamic tissue that remodels continuously in response to local 
mechanical and chemical stimuli. This process can also result in maladaptive 
ectopic bone in response to injury, yet pathological differences at the molec-
ular and structural levels are poorly understood. A number of in vivo models 
exist but can often be too complex to allow isolation of factors which may 
stimulate disease progression. A self-structuring model of bone formation 
is presented using a fibrin gel cast between two calcium phosphate ceramic 
anchors. Femoral periosteal cells, seeded into these structures, deposit an 
ordered matrix that closely resembles mature bone in terms of chemistry 
(collagen:mineral ratio) and structure, which is adapted over a period of one 
year in culture. Raman spectroscopy and X-ray diffraction confirm that the 
mineral is hydroxyapatite associated with collagen. Second-harmonic imaging 
demonstrates that collagen is organized similarly to mature mouse femora. 
Remarkably, cells differentiated to the osteocyte phase are linked by canaliculi 
(as demonstrated with nano-computed tomography) and remained viable 
over the full year of culture. It is demonstrated that novel drugs can prevent 
ossification in constructs. This model can be employed to study bone forma-
tion in an effort to encourage or prevent ossification in a range of pathologies.
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physicochemical characterization of mature mineral production 
and the effect of this changing environment on incorporated 
cells. There are also several modalities to recreate pathological 
ossifications in animal models, including the overexpression or 
inhibition of mole cular osteoinductive factors, trauma induc-
tion, and heterotopic implantation.[16–18] However, some of these 
models are not fully representative of the pathological states, 
requiring the use of a large number of animals; or are too com-
plex to allow the isolation of individual contributing factors in 
early phase bone formation, which makes it objectively difficult 
to answer some essential questions on biological ossification.[16]
Developing novel ways to produce ossified tissue is essential 
for several scientific reasons. From a biological perspective, new 
models will help to develop a deeper understanding of the funda-
mental processes underlying both early bone development and the 
pathological ossification events following trauma or injury.[4,5] New 
approaches to develop bone-like materials are also required for the 
augmentation of bone defects and ultimately the replacement and 
surgical transplantation of tissue grafts.[1,19–21] In this context, the 
present work focused on developing a new, biological model of 
bone tissue formation, which would allow long term, whole con-
struct testing of potential therapeutic drugs or of anabolic factors 
in a less complex environment. The aim was to develop a system 
that could in future be easily manipulated biochemically and 
biomechanically to simulate the ossification microenvironment 
encountered in both normal and pathological environments and 
that could ultimately be applied to investigate both biological and 
physical research questions. To develop this system, we used oste-
oblastic cells extracted from the periosteum of rat femoral bones. 
Periosteum cells are the main determinants in the reparative 
phase of bone fracture healing, when they interact with the tem-
porary fracture callus, which serves as a scaffold for the formation 
of new bone.[1,22–25] Furthermore, they have been associated with 
heterotopic ossification (HO) and have the ability to give rise to 
endochondral bone when implanted in muscle, and therefore may 
be central to this condition.[17,24,26] Following isolation, periosteum 
cells were seeded into fibrin hydrogels, which critically permit self-
assembly and imaging of a de novo collagen matrix, and because 
as materials, fibrin scaffolds have structural and biochemical 
similarities to the microenvironment of the callus formed early 
in fracture healing.[27–29] Both cortical and trabecular bone show 
a similar matrix alignment at the microscale, which is essential 
for development and mechanical resistance. To mimic this impor-
tant feature, the environment of the fracture callus was further 
emulated by introducing two calcium phosphate (CaP) anchors 
at the extremities of the culture dish. These anchors served to 
enhance retention of the forming matrix, which created tension 
forces centrally that encouraged alignment along the direction of 
force, as seen in bone.[30] Instead of providing the constructs with 
preformed hydroxyapatite (HA) anchors (similar to the main con-
stituent of the inorganic component of bone), we have provided 
beta-tri-calcium phosphate (β-TCP)/brushite anchors as they were 
more soluble and hence could provide the tissues with a local 
source of calcium and phosphorus to aid in ossification. Over 
time, constructs self-structure from a homogenous polymer, in 
the form of fibrin, into aligned, heterogeneous structures. Sam-
ples were characterized over a period of 1 year in culture in terms 
of matrix organization, cell behavior, and mineralization using a 
combination of optical, spectroscopic, and chemical techniques. 
We show here that antiosteogenic compounds can reverse the 
progression of ossification, indicating potential for interventional 
studies.
2. Results
2.1. Early Events
Early developmental events commence with remodeling of the 
callus-like matrix following cell attachment to the scaffolds. 
The presence of the two calcium phosphate anchors causes the 
matrix to contract around the two holding points (Figure 1a). 
Over time, this retention results in the formation of tension 
in the soft tissue between the two anchors, which causes 
alignment at the cellular and molecular level along the direc-
tion of the force (Figure 1b). The presence of the two anchors 
is essential for generating these structures as fibrin gels, 
which are seeded with cells but are not provided with anchors 
do not become organized by cells and contract randomly 
(Figures S3 and S4, Supporting Information).
The matrix starts to become mineralized from the bone-like 
anchor regions as early as 10 d, and these deposits grow over 
the subsequent days as mineral nodules form throughout the 
structure (Figure 1b). Mineralization nodules can be detected 
by whole-mount Alizarin Red staining as early as day 11, 
starting from the anchors (Figure 1b,c). The homogeneous 
matrix changes over the first three weeks in culture, with a 
visually distinct matrix advancing from the anchors toward the 
center until the structures appear radically different following 
extended periods of time (3 months) (Figure 1d).
As a negative control, we used a non-cell seeded fibrin-based 
structure (Figure 1a). Although some shrinkage and a level of 
dispersed calcification were noted in these structures, they did 
not exhibit the high levels of structural organization that were 
notable in our cell-seeded scaffold structures, suggesting that 
the embedded cells are critical to enabling the reorganization 
and subsequent mineralization of the bone-like structures.
2.2. Initiation and Development of Ossification
The evolution of mineral and matrix in constructs over time 
is presented in Figure 2, which contains microtomographic 
3D reconstructions of early (12–15 d) and mature constructs 
(3 months–1 year) developed with periosteal cells. These high-res-
olution microtomographies, acquired at sequential time points, 
also revealed that mineralized matrix started forming in early 
stages at the calcium–phosphate extremities in the absence of fur-
ther osteogenic supplementation (Figure 2a–c), and progressed 
with subsequent osteogenic supplementation throughout the 
entire length of the constructs, until the structures became fully 
ossified after approximately 3 months (Figure 2d,e). The initial 
fibrin structure became gradually replaced with greater-density 
matrix (Figure 2h–j), which after 3 months contained deposits of 
high density mineral independent of the main bone-like struc-
ture (Figure 2k,l). Thus, a combination of clinically relevant 
types of ossification were noticed in this system: the first type—
starting from the bone-like ends—resembling fracture repair; as 
Adv. Biosys. 2018, 2, 1700156
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Figure 1. Early construct development. a) Fibrin scaffold is reorganized around the retention points over the first week in culture. Control constructs, 
developed without cells showed a small degree of contraction over 7 d, but remained as flat gels and did not assemble into 3D structures. b) Tensile 
forces between the two anchor points cause cell alignment before day 6 (left). Mineralization nodules are observed throughout the structure after 10 d 
(middle). c) Mineral deposits are not noticeable following 7 d but individual mineralization points can be observed 4 d later in the close proximity of the 
calcium phosphate source. Scale bars b = 50 µm (Day 6, 10), 200 µm (Day 11). d) Changes in the fibrin template are visually noticeable at 14 d, with 
a distinct matrix forming from the anchor regions toward the center, until the constructs appear to be fully covered with the new matrix at 3 months.
Figure 2. Development of mineralization and matrix over time. a–n) Reconstructed µCT images of early constructs (days 12–15, a–c/h–j) and mature 
constructs (3 months–1 year, d–g/k–n), illustrating the development of ossification over time. a–e) Mineralization starts at the anchors (a) and pro-
gresses over time throughout the entire length of the constructs (b,c) until the mineral covers the entire structure of constructs (d,e). Bottom panel 
presents color-coded versions of the constructs above, illustrating the development of the new matrix over time. The fibrin template (green), which 
predominates after j) 15 d, is progressively replaced over time with new matrix (blue) (h–j) until it becomes completely substituted after 3 months with 
the new, denser matrix, which also contains discrete deposits of high-density mineral (red) (k,l). Following a year in culture, the constructs contain 
considerable amounts of the high-density mineral (m,n). Cropped section illustrates the high-density material comprising the outer layer of constructs 
after a year in culture. Scale bars = 2.5 mm.
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well as an isolated form, distant from the main bone-like struc-
ture, resembling mineral deposition in soft tissues as seen in 
ectopic ossification.[1,4,5] During the subsequent culture period 
up to one year, this new matrix becomes very dense and compact 
(Figure 2f,g/m,n), containing a high-proportion of mineral, parti-
cularly on the outside surface (Figure 2g).
2.3. New Matrix Characteristics
As indicated by tomographic analysis, constructs became 
mineralized through a process that was more complex than a 
simple calcification, i.e., the precipitation of calcium phosphate 
compounds on the fibrin matrix. Microtomographies indicated 
significant amounts of new, greater-density matrix colocalized 
with mineral deposits, which formed gradually throughout 
the culture period, indicating that a process of ossification was 
taking place. The nature and characteristics of these matrix 
components were analyzed through a combination of mole-
cular, spectroscopic, and optical methods, which revealed an 
abundance of structural proteins associated with the extracel-
lular matrix (ECM) of connective tissues. Figure 3a illustrates a 
comparison between the novel matrix observed in early stages 
(15 d) using µCT, and a high-resolution compositional Raman 
map developed based on the signal corresponding to one of the 
organic components identified in abundance, CH2 (1447 cm−1), 
indicative of collagen. The latter analysis revealed that a higher 
amount of this compound was distributed in a similar pattern 
observed with CT, at this equivalent time point. In bone, col-
lagen is produced by osteoblastic cells during the assembly of 
the ECM and accounts for ≈90% of the organic component.[31] 
As such, its simultaneous deposition with the early mineral can 
be used as an indication of early ossification. Spectral analysis 
of constructs which had just completed undergoing the contrac-
tion phase (7 d), revealed that the CH2 band was accompanied 
by other bands such as amides I and III (1646 and 1316 cm−1, 
respectively), proline and hydroxyproline (861 and 872 cm−1, 
respectively), major components of collagen, and later, at 
day 12, by phosphate compounds in the central and inter-
face regions, indicative of mineral formation and co-localized 
with the organic components (Figure 3b).[32] All the mineral 
detected using Raman spectroscopy at these early time points 
was different from the anchor material (Figure S5, Supporting 
Information), the majority being octacalcium phosphate (OCP, 
954 cm−1). OCP is thought to be an intermediate in hydroxyapa-
tite formation in bones, enamel, and dentin and its presence 
as an intermediate phase in the formation of bone and dentin 
mineral has been a subject of great debate over the past decades. 
It has more recently been confirmed and described as taking 
place during in vivo mineralized tissue formation and in patho-
logical dental and renal calcifications.[33–36] It has also been iden-
tified using similar Raman spectroscopy analysis in cultured 
calvarial bone tissue explants.[37] The presence of a novel phos-
phate phase in our system suggests a cell-mediated mineraliza-
tion, but also indicates an advantage of our system in terms of 
the ability to simulate the temporal evolution of bone mineral.
At the end of an initial month in culture, a regime of full 
osteogenic supplementation was commenced, containing addi-
tional ascorbate, β-glycerophosphate, and dexamethasone. The 
purpose of this additional supplementation was to encourage 
ossification to progress more rapidly towards the center, at a 
point when the matrix was robust enough to maintain integ-
rity during the rapid dissolution of the remaining fibrin caused 
by the new matrix replacement. Raman spectroscopic analysis 
performed following 2 months of supplementation revealed the 
presence of the complete set of peaks that have been reported 
Adv. Biosys. 2018, 2, 1700156
Figure 3. Chemical characteristics of the newly forming matrix. a) Comparison of a micro-CT reconstruction and a high-resolution Raman map, devel-
oped based on the CH2 peak (1447 cm−1) showing a similar distribution of the denser, newly forming matrix in constructs which are 2 weeks old. b) As 
early as day 7 (yellow), peaks corresponding to collagen can be detected, including amide I, III, CH2, but also hydroxyproline (Hp) and phenylalanine 
(Pa). 5 d later (day 12, brown), small phosphate peaks corresponding to OCP start to emerge in the central and interface regions. Spectra from mature 
(3 month constructs, pink) are provided for comparison. c) Spectra from spatially distinct regions from a mature construct (3 months) showing in 
all cases a strong hydroxyapatite content colocalized with all the components associated with collagen. Spectra contain all peaks detectable in bone 
using this technique.
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to be present in mature bone, and in all regions investigated, 
including the center (Figure 3c).[32,38] Interestingly, the mineral 
detected at this time point was the complex bone hydroxyapatite 
(957–962 cm−1), suggesting a maturation process from the inter-
mediate phases, and was in all cases associated with collagen.
In terms of localization and organization of collagen in 
constructs, as early as day 7, collagen was detected using 
whole-mount picrosirius red staining, abundantly around the 
edges in the vicinity of the two anchors (Figure 4a) and adja-
cent to the anchors, where it appeared to emerge from cell-like 
structures (Figure 4b). As mineral deposits composed of calcium 
phosphate advance toward the center during the first month of 
culture (Figure 4c), the organic matrix progresses as well. Mul-
tiphoton microscopy was similarly employed to image collagen in 
3D in live constructs by making use of the nonlinear optical effect 
known as second-harmonic generation generated exclusively by 
collagen when exposed to a laser of an infrared/near-infrared 
wavelength (Figure 4d; Figure S6, Supporting Information). 
Where structural information was necessary, such as the spatial 
dynamics between osteoblasts and their secreted matrix protein, 
second harmonic imaging was used in combination with an addi-
tional high-resolution optical technique, two-photon excited fluo-
rescence (TPEF), which allowed the simultaneous visualization of 
collagen and viable cells, stained with a cell-permeant fluorescent 
dye (Calcein acetoxymethyl (AM)), at a cellular resolution but over 
the tissue length scale.[39] 3D analysis of constructs that were cul-
tured for approximately one month showed significant deposits 
of collagen arranged in pocket-like structures in the interface 
regions, surrounded by cells (Figure 4d illustrates an example). 
Further analysis using second harmonics (Figure 4e) revealed 
that the central region of constructs did not contain detectable 
deposits of collagen at this time point, indicating that the ossifica-
tion had not progressed as far up to that time point, but also that 
the collagen species secreted by cells centrally had not reached the 
sufficient maturity (i.e., the noncentrosymmetrical, triple-helical 
structure) required to reflect half the wavelength of the incoming 
laser and thus to be detected using this technique.[39,40]
Throughout the additional osteogenic regime, over the fol-
lowing months, ossification progressed at the mm scale until 
the two sides met centrally, showing the same pattern of organ-
ization of collagen pockets as observed in murine femoral 
bones (Figure 4e). Together, these results suggest a progressive 
deposition and maturation of mineralized collagen as seen in 
bone formation and fracture repair.[41]
2.4. Cellular Development in Constructs
During the culture period, the combination of biomechanical 
and chemical factors (i.e., presence of tensile forces, contin-
uous source of calcium phosphates and osteogenic supplemen-
tation) ultimately had an influence on the specialization of the 
stem cells embedded in the constructs toward an osteoblastic 
lineage and subsequently recapitulated successive phases of 
ossification, including cell attachment to scaffold, clot remod-
eling, and matrix production.[42,43]
Optical analysis of the cellular morphological features during 
the months of culture revealed a pronounced restructuring of 
the cytoskeleton (Figure S7, Supporting Information), showing 
the formation of extensive projections characteristic of osteo-
cytes and of long microcanals.
At the molecular level, cells present after a period of 
5 months expressed the osteocytic marker sclerostin (SOST), 
a negative regulator of bone formation and an inhibitor of 
osteoblastic activity, on their outer membranes and in their 
Adv. Biosys. 2018, 2, 1700156
Figure 4. Development of the collagenous matrix in constructs. 
a,b) Images of 7 d constructs stained with Sirius Red for collagen. Left 
image illustrates high amounts of collagen in the marginal region adja-
cent to the brushite anchor; right image demonstrates collagen emerging 
from cell-like structures next to the anchor. Scale bars = 200 µm. c) Micro-
XRF mapping of live constructs over 21 d, based on Ca and P, the inor-
ganic components of bone and S, as an indicator of the organic matrix. 
Maps show the progression and co-localization of Ca and P from the 
anchor towards the center during this period of development up to 
one month. Scale bar = 4mm. d) An example of a 3D reconstruction of 
cells (TPEF) and collagen (SHG), simultaneously visualized in 1 month 
constructs. Collagen is present in “pocket”-like deposits. Scale bars = 
100 µm. e) SHG visualization of collagen in distinct regions at different 
time points. Collagen is abundant around the anchor areas, but not 
detected in the central region at 1 month. Over the subsequent 2 months, 
the collagenous matrix extends into the tissue at the mm level, displaying 
a level of organization similar to murine femora (bottom image).
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surroundings, which resembled cell networks (Figure 5a).[44–46] 
Further networks rich in sclerostin but also podoplanin 
(PDPN), a marker for the embedding osteoid osteocyte, and 
which is involved in reorganization of the cytoskeleton, could 
also be detected following the very extended culture time of 
1 year (Figure 5a illustrates an example).[46,47] Sclerostin and 
podoplanin messenger RNA (mRNAs) were also detected 
at these late (5 months) and very late time points (1 year) 
(Figure 5b), suggesting an active role of the cells in building 
and remodeling the bony matrix.
Interestingly, the mineral to matrix ratio of these con-
structs at the latter time point reached a value similar to that 
of bone, with mineral occupying ≈70% of the total content 
(Figure 5c).[31] Moreover, the mineral was confirmed to be the 
mature bone hydroxyapatite using X-ray diffraction analysis 
(Figure S9, Supporting Information).[48] High-resolution optical 
analysis of the cells in the most mature constructs (1 year) 
demonstrated further osteocytic morphological features. Cells 
at the surface of constructs, imaged using scanning electron 
micro scopy (Figure 6a), appeared embedded in the heavily 
mineralized matrix. These cells contained a high number of 
large projections emerging from the cell bodies and reaching 
adjacent cells, as seen in bone.[49,50] Synchrotron radiation com-
puted tomography (srCT), which enabled resolution down to the 
nanoscale, was used to visualize cells located below the surface, 
inside the constructs.[51,52] Figure 6b illustrates an example. The 
tomographic reconstruction further confirmed the presence of 
a complex canalicular network that linked the embedded cells, 
the first time that such elaborate structures have been attained 
using an in vitro culture. These channels were visualized using 
micro-X-ray fluorescence (µ-XRF) to provide a chemical map of 
the tissue structures (Figure 6c). Lacunae, which were shown 
Adv. Biosys. 2018, 2, 1700156
Figure 5. Detection and localization of bone markers in mature constructs. a) Immunohistochemistry of constructs, showing expression of osteocytic 
marker sclerostin on the surface of cells and in neighboring network-like structures at 5 months (middle). The matrix of 1-year-old constructs contains 
long networks, where podoplanin could be detected (right). Scale bars = 100 µm. b) mRNA for sclerostin and podoplanin was detected at these time 
points as well. Results are presented compared to a rat osteosarcoma cell line as positive control. UMR-106 produces sclerostin and podoplanin con-
tinuously. Please note cycle threshold (Ct) is inversely proportional to the amount of target nucleic acid in the sample. npdpn = 4 (umr, 5 m), 2 (1 year). 
nsost = 4 (umr), 2 (5 m, 1 year). ngapdh = 4 (umr, 5 m), 2 (1 year). c) The inorganic component of constructs following a year in culture equals approxi-
mately 70% of the total content, n = 3.
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to house cells expressing osteocytic markers, were surrounded 
by a matrix rich in calcium and phosphate salts. The presence 
of a canalicular network was further supported by this analysis, 
which showed a sulfur-rich network (indicative of the presence 
of protein), which permeated through and between the lacunar 
structures (Figure 6c). Similar osteocytic structures, containing 
cellular DNA, were observed at earlier time points as well using 
histological analysis (Figure S8, Supporting Information).
Taken together, these results suggest that the microenviron-
ment inside constructs, which developed into mature, mineral-
ized collagen, reached a level of ossification similar to in vivo 
bone following long-term culture, which allowed the differenti-
ation and survival of osteocytic cells over an extended, clinically 
useful period of time.
Osteocytes are extremely difficult to differentiate in vitro, 
as these mature cells form under complex conditions in their 
environment.[45] They are also very difficult to investigate in 
vivo due to their localization, embedded in lacuno-canalicular 
networks in hard bone, and their final stage differentiation into 
mitotically inactive cells.[45] Following isolation, culturing these 
cells require complex supplementation regimes to prevent a 
quick de-differentiation into osteoblastic phenotypes. Although 
standard immortalized osteocyte cell lines (e.g., MLO-Y4) are 
available, they are not entirely representative due to reduced 
marker expression, particularly sclerostin.[53] As a consequence, 
to this date there are few models available for ex vivo or in vitro 
study of osteocytes and certainly none that allow for the long-
term growth of these cells.
This work demonstrates that it is possible to fine-tune a pri-
mary osteoblastic cell population toward an osteocytic pheno-
type in a physiologically relevant system that develops into bone 
tissue at most levels, including cellularly (osteoblast and osteo-
cyte development), compositionally and structurally (organized 
collagenous matrix production and mineralization). Although 
primary osteoblast to osteocyte cell transition has recently 
been reported in 3D by a few research groups, our model dif-
fers in the close recapitulation of complex in vivo conditions 
and in the self-structuring process as opposed to a preformed 
organic–inorganic matrix template (e.g., collagen scaffold 
with embedded HA particles).[45,54,55] As such, our constructs 
Adv. Biosys. 2018, 2, 1700156
Figure 6. Development of bone cells in constructs. a) SEM images of cells in constructs after 12 months of culture, showing cells embedded in the 
significantly mineralized matrix. The main cellular structure in a has been false-colored to allow a better visualization. There are many podocytes 
embedded in the heavily mineralized matrix. Cells communicate through extensive projections. b) Synchrotron radiation computed tomography illus-
trating a typical osteocyte lacuna (L) with emerging canaliculi (C) that branch into the tissue. c) XRF maps based on S, Ca, P showing network-like 
structures throughout the matrix and connecting adjacent lacunar-like structures (arrows). Scale bars = 200 µm.
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survive over much greater periods of time (i.e., 12 months com-
pared to a few weeks); as well as developing over a real tissue 
length scale. We have carried out a pilot study over 3 weeks in 
culture to test novel compounds that can inhibit the ossifica-
tion process, obtaining promising results. In particular, treat-
ment with compound CD1530, a nuclear retinoic acid receptor 
gamma agonist (RAR-γ) used in treating acquired and con-
genital heterotopic ossification, prevented the advancement of 
ossification toward the center by 99% compared to controls in a 
21 d study (Figure 7).[56,57] Similarly, a second compound tested, 
LDN193189, which is a selective inhibitor of the BMP type I 
activin receptor-like kinase ALK2, ALK3, and which has been 
successfully used to reduce heterotopic ossification in trans-
genic murine models of FOP, when administered to constructs, 
was effective in reducing the mineralized matrix volume cen-
trally by 70% compared to controls (Figure 7).[58]
The marked reduction in matrix volume following admin-
istration of these compounds was further confirmation that 
mineralization takes place through a cell-mediated route, as 
encountered during normal long bone formation, fracture 
repair, and heterotopic ossification.[57]
3. Conclusion
Here, we demonstrated how simple homogeneous materials 
(fibrin) may be structured and modified by populations of cells 
to create complex tissues by making relatively simple geomet-
rical and chemical modifications to the culture system. The 
composition of the tissues was probed using a suite of chemical 
analysis techniques that allowed us to identify the distribution 
and local organization of matrix components.
After even short periods of culture, the tissues were shown 
to be heterogeneous in composition and structure, with col-
lagen and mineral distributed in spatially distinct regions (for 
a summary, see Figure S2 in the Supporting Information). 
Importantly, our Raman spectral data suggested that the min-
eral deposited within the tissue was associated with collagen as 
opposed to precipitated on the surface of the tissue. The mech-
anism of tissue formation was similar to a fracture callus and 
we demonstrated that the distribution of collagen and mineral 
within the tissue was similar to that found in mouse femora. 
We have further shown that the initial phosphate species con-
vert to HA, as encountered in biological tissues. This transition 
can be recreated in our system via intermediate phases (such 
as OCP).
Our model displays promise for use in many research areas, 
ranging from tissue engineering and bone replacement mate-
rials, to heterotopic ossification research. It could also be a valu-
able tool for assessing material properties, such as the transi-
tion of harmful ions from medical devices into the surrounding 
tissues, in a realistic 3D environment. Moreover, it could serve 
as a screening platform for testing a wide range of drugs that 
suppress or enhance the ossification process. This means that 
our system could potentially reduce the number of animals 
required for skeletal research by providing an intermediate plat-
form between in vitro and in vivo research.
Moreover, we briefly present here (Figure S10, Supporting 
Information) some examples showing the flexibility of this 
system in developing embedded cells of different human and 
animal skeletal origin (including primary chondrocyte and 
tendon cells). We also provide a brief example of our early work 
toward vascularizing the constructs (Figure S10c, Supporting 
Information), a step closer to mimicking the in vivo bone char-
acteristics. Finally, we present an account of the wide range of 
cells which have already been tested in our system (Table S1, 
Supporting Information).
4. Experimental Section
Isolation of Primary Rat PO Cells: Femurs from left and right 
rat limbs were excised and surrounding muscular and connective 
tissue was removed. Femurs were stored in phosphate buffered 
saline (PBS) solution (pH 7.4; Gibco, Life Technologies, Thermo 
Fisher Scientific, UK) until use. Periosteal cells were extracted from 
the periosteum via enzymatic digestion using a cocktail containing 
2.5 mg mL−1 collagenase I, 0.7 mg mL−1 collagenase II and 0.5 units per 
ml dispase I, in PBS (Gibco, Life Technologies, Thermo Fisher Scientific, 
UK). Bones were incubated with this solution at 37 °C for 1 h in a 5% 
CO2 atmosphere. Following incubation, tubes containing bones and 
solution were shaken rigorously for 30 s to detach the remaining cells. 
Solutions were then pooled and filtered using 70 µm filters (Falcon, 
Becton Dickinson, UK). Cells were recovered using centrifugation 
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Figure 7. Ossification-inhibiting compounds decrease matrix and mineral 
formation in constructs. a) Administration of two inhibiting compounds 
in a pilot study lasting 21 d appeared to reduce the progression of ossi-
fication in treated constructs compared to controls. CD1530 (1 × 10−6 m) 
significantly reduced mineralized matrix formation following 21 d of 
culture compared to equivalent controls. LDN193189 (25 × 10−9 m) also 
appeared to be effective. b) Comparison of the mineral volume located in 
the central portion of constructs following 21 d of culture, quantified by 
morphometric CT analysis. Constructs treated with CD1530 showed an 
average of 99% less mineral in this region compared to controls, which 
was statistically significant, whereas the group treated with LDN193189 
showed 70% less mineral, although not significant. Data are presented 
as means ± SD. *p < 0.05, n = 3.
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at 21 °C, 1400 rpm for 6 min. The supernatant was discarded and 
the resulting pellet was resuspended in 10 mL D20 growth medium 
(Dulbecco’s modified Eagle medium (DMEM) containing 20% serum). 
Approximately 1 million PO cells from each bone were cultured for 
10–12 d in D20 medium (Figure S1, Supporting Information).
Cell Lines: Cells originating from cell lines mouse calvarial osteoblasts 
(MC3T3-E1/2T3s) were obtained from the European Collection of 
Authenticated Cell Cultures and were cultured according to standard 
procedures in Minimal Essential Medium Eagle (MEM) Alpha 
Modification (10% fetal bovine serum, 1% P/S, 2.4% l-glutamine) 
(Sigma-Aldrich, Germany).
Tissue-Engineered Constructs: Constructs were developed by seeding 
fibrin hydrogels with osteoblastic cells, either periosteal cells from 
rat femurs, or from cell lines such as MC3T3-E1 or 2T3. The fibrin 
scaffolds were produced through the interaction of the normal plasma 
components thrombin and fibrinogen. Bovine-derived thrombin 
powder (Calbiochem, EDM Chemicals; 1KU) was reconstituted using 
0.1% w v−1 bovine serum albumin (BSA) and 5 mL F12K Nutrient 
Mixture (1×) with Kaighn’s modification (Gibco Life Technologies) 
to make a final concentration of 200 units per mL. Powdered bovine 
fibrinogen (Sigma Life Sciences) was reconstituted in F12K Nutrient 
Mixture (1×) with Kaighn’s modification (Gibco Life Technologies) at a 
ratio of 20 mg mL−1. Thrombin was added to a solution containing the 
cell culture medium (either DMEM or αMEM) at a ratio of 50 µL mL−1 
solution. The antifibrinolytic agents aminohexanoic acid (200 × 10−3 m) 
and aprotinin (10 mg mL−1) were added to the thrombin solution at a 
ratio of 2 µL mL−1 in order to reduce the degradation rate of the fibrin 
gel, in order for it to match the rate of new matrix formation so that 
the mechanical integrity of the tissue could be maintained over longer 
periods of time. Hydrogels were generated by mixing 500 µL thrombin 
solution with 200 µL fibrinogen. Thrombin cleaves small peptides from 
the fibrinogen chain, producing soluble fibrin monomers, which then 
cross-link into an insoluble, polymerized fibrin clot. Gels were allowed 
to polymerize for 30–40 min. Cells were seeded into the fibrin constructs 
immediately following gel polymerization; at a density of 100.000 per 
2 mL of cell culture medium.
β-Tricalcium Phosphate Anchors: 2.5 g of β-TCP powder (<125 m 
particle size) was added per 1 mL of orthophosphoric acid (3.5 m) to 
generate a paste, composed of a mixture of brushite and β-TCP. The 
liquid mixture was poured into individual, preshaped wells of molds, 
placed on top of a shaking platform, to encourage uniform setting inside 
the shapes. 1.4 cm stainless steel insect pins (Austerlitz minutiens, Fine 
Science Tools, USA), with a diameter of 0.20 mm were inserted into the 
individual wells on the molds before the mixtures advanced into a solid 
state. The mixtures containing the pins were allowed to fully harden for 
3–4 h and were sterilized overnight using UV light exposure, as well as 
with 70% EtOH for 30 min on the day of use. The final anchors had a 
trapezoidal shape and measured approximately 3 mm × 4 mm × 4 mm 
in height. The anchors were mounted on solidified silicone elastomer 
bases (1.5 mL of Sylgaard184, Dow Corning) placed at the bottom of 
individual wells on six-well culture dishes. Attachment was performed 
using the pins, using 2 anchors per well, which were applied at a 
distance of 1.5 cm from each other.
Osteogenic Supplementation of Periosteum Cell Constructs: Constructs 
developed with periosteum cells were supplemented following 1 month 
of culture with full osteogenic DMEM culture medium containing 
β-glycerophosphate (10 × 10−3 m), ascorbic acid (0.1 × 10−3 m), and 
dexamethasone (10 × 10−9 m) (Sigma Aldrich, Germany), to encourage 
new matrix deposition along the entire length of the constructs.
CD1530 and LDN193189 Supplementation: RAR-γ agonist CD1530 
and ALK2/3 inhibitor LDN193189 were administered in the culture 
medium of constructs at a concentration of 1 × 10−6 and 25 × 10−9 m, 
respectively. Starting with day 7 of culture, constructs received one dose 
every 2 d (6 doses total) of either CD1530 or LDN193189. Controls 
received an equivalent amount of dimethyl sulfoxide, which was used in 
drug dissolution.
Supplementation of Other Constructs: Following 7 d of development, 
the MC3T3-E1 constructs were supplemented with ascorbic acid 
(250 × 10−6 m final concentration) and proline (50 × 10−6 m final 
concentration) every 2 d, to stimulate collagen deposition (Sigma Life 
Sciences, Germany).
Raman Spectroscopy: Confocal Raman spectroscopy was used to 
detect and spatially resolve specific chemical groups associated with 
mineralized collagen deposition through the constructs. Maps and 
spectra were acquired using a confocal Raman microscope (Alpha 
300R, WITec, Ulm, Germany), equipped with an Acton SP2300 Imaging 
Monochromator/Spectrograph (Princeton Instruments, MA, USA), fitted 
with a 300 g mm−1 with 750 nm blazing grating, and a 785 nm 250 mW 
diode laser (XTRA II, Toptica photonics, Munich, Germany).
Spectra were acquired from various points on the constructs, 
including the anchor; the interface between the anchor and the soft 
tissue and the central portion, via a 20X (NA = 0.45) objective lens 
and using an integration time of 3 s and 20 accumulations. Data were 
accumulated and exported using the WITec Control software version 1.6 
(WITec, Ulm, Germany).
Micro-Computed Tomography (µCT): X-ray microcomputed 
tomography allowed a nondestructive 3D visualization of constructs 
and offered detailed insight into the initiation and development of 
ossification.
A micro-computed tomography system (µCT) (SkyScan 1172, Bruker 
Instruments, Germany) was used to evaluate mineralization and matrix 
development in constructs over time. Constructs were removed from the 
culture medium and were placed vertically inside plastic tubes, on a rotating 
stage located at 260.650 mm distance from the X-ray source and 347.109 mm 
from the detector. High-resolution scans were performed at ambient 
pressure using the cone-beam imaging system, composed of a Hamamatsu 
X-ray source with a voltage of 80 kV and a tube current of 100 µA. 
The X-ray detector consisted of an 11 Mp X-ray camera of a 9.01 µm 
pixel size, generating images of 6.76 µm pixel size. 2D cross-section slices 
of the constructs were acquired at a rotation step of 0.2°, with two frames 
averaging per step and an exposure time of 1050 ms. Acquired images 
were 3D reconstructed using the Bruker micro-CT NRecon Software 
(v. 1.6.10.2). For removal of scanning artifacts, several reconstruction 
parameters were adjusted during reconstruction. The beam hardening 
parameter was set to a value of 30 to correct for the surface-to-depth 
density gradient caused by increased X-ray attenuation at the surface 
of the constructs. A ring artifact correction was set to a level of 9. The 
smoothing parameter was adjusted to a value of 4. These optimized, 
construct-specific settings were used for all time points investigated.
For constructs subjected to drug treatment, as these samples were 
less ossified and hence less dense, acquisition settings were adjusted to 
an X-ray voltage of 50 kV and a tube current of 100 µA; an image pixel 
size of 13 µm, with an exposure time of 510 ms, a rotation step of 0.4° 
and a frame averaging value of 2. Flat field correction was performed for 
image clarity and no ring artifact correction was applied.
Transfer functions were created in the CTVox software that allowed 
segmentation of the high density matrix components, as well as for 
creating color-coded versions of the components in the constructs. The 
same transfer function was used for all constructs in the same group of 
investigation.
Volumetric Analysis: Volumetric quantification of the mineral 
component was performed using morphometric analysis in the CTAn 
software (v. 1.13). 200 slices from equivalent regions in the central 
portions of control and drug treated constructs were isolated and a 
threshold of 220–255 was applied to segment the high density mineral 
component. 3D analysis of the segmented volume was performed and 
data was averaged to obtain the final volume in mm3.
Synchrotron Radiation-Computed Tomography: srCT analysis was 
conducted on the nanoimaging beam line ID16 at the European 
Synchrotron Radiation Facility (ESRF) in Grenoble, France. Constructs 
were fixed with 4% formaldehyde and dried for 30 min at 50 °C. 5 mm 
samples of constructs were excised and placed on the rotating stage. 
Images were acquired at a resolution of 50 or 100 nm and a number of 
slices of 65–200 was acquired and used for 3D reconstruction.
Second Harmonic Imaging and Two-Photon Excitation Fluorescence: 
A multiphoton microscopy system was used to observe collagenous 
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matrix formation in constructs using the optical effect of second 
harmonic generation (SHG). To concomitantly visualize collagen and 
cells, constructs were stained with the fluorescent dye Calcein AM 
(Sigma-Aldrich, Germany) at a ratio of 2 µL mL−1 of Opti-MEM culture 
medium (Gibco, Thermo Fisher Scientific, USA) to assess viability and 
distribution of cells.
The microscopy system consisted of a Zeiss LSM710 NLO (Zeiss 
Gmbh, Germany) coupled to a Ti:Sapphire mode-locked Coherent 
Chameleon Vision II laser. Collagen and fluorescent cells were 
imaged using SHG and TPEF between 385–475 and 480–655 nm, 
respectively. Photons were collected through a 10× Plan Apo 0.45 N.A. 
and the two-photon laser was tuned at 860 nm. The presence of 
collagen was confirmed by spectral imaging and collecting the 
second harmonic signal at 430 nm via a 10× Plan Apo 0.45 N.A. or 
40× Plan-Apo 0.95 N.A. objective. Where z-stacks were acquired, 
a slice interval of 6 µm was used. Images were visualized in ZEN 
2009. Cell viability measurements were taken at different time points 
using Calcein AM, as described above and imaging was performed 
using either the Zeiss LSM710 NLO or a Leica DM2500/TCS SPE 
Confocal (Leica Microsystems, Wetzlar, Germany). Where z-stacks 
were acquired, a step size of 0.50 µm was used and excitation was 
performed using a 488 nm laser.
Elemental characterization Using Micro X-Ray fluorescence: A micro 
X-ray fluorescence system (M4 Tornado, Bruker Nano Gmbh, Berlin, 
Germany) was used to generate spatially resolved elemental maps of 
constructs and to investigate mineral and organic matrix distribution 
using the localization of Ca, P, and S in constructs.
The machine contains a rhodium µ-focus X-ray tube and a 
polycapillary lens, used to focus the X-rays to a spot size of 25 µm. 
Recordings were taken without sample processing, at room temperature 
and ambient pressure. The X-ray tube voltage used was 50 kV and tube 
current was 400 µA. µXRF spectra and maps from constructs of different 
ages were acquired using a 50 µm spot distance, 25 µm spot size, and 
50 ms per pixel exposure time.
High-resolution elemental mapping of the lacunar structures and 
matrix of 1 year constructs was performed on flat, 4 µm thick slices (see 
Histoprocessing) using a spot size of 25 µm, distance of 5 µm, with 
10 ms per pixel exposure time and 100 frame counts. Measurements 
were recorded under vacuum, at ≈800 mbar. Elemental maps were 
formed in real time by integrating the photon counts around the 
emission lines of: calcium (Kα1 3.692 keV), phosphorus (Kα1 2.010 keV), 
sulfur (Kα1 2.309 keV), generating an image where pixel intensity was 
proportional to the number of X-ray counts/second per electronvolt 
(eV) from each measured point on the construct. Thus, pixel intensity 
increased with X-ray counts, with maximum pixel intensity normalized 
to the highest count rate per eV for each element of interest, across the 
entire construct.
Thermal Isolation of Mineral: Constructs were removed from culture 
and their calcium phosphate anchors were excised. Remaining tissues 
were dried at room temperature overnight and weighed using an Ohaus 
Pioneer Plus analytical balance (Ohaus, NJ, USA). Tissues were then 
introduced into a 900 °C hot oven for 13 h to remove organic matter 
(Carbolite CWF1300, Carbolite Gero, Hope Valley, United Kingdom). 
Following this period, the inorganic matter isolated was weighed and the 
percentage mineral content was calculated.
X-Ray Diffraction: X-ray diffraction was used to determine the 
crystalline composition of the samples. The crystals produced from the 
samples following 13 h of heating in a furnace were ground into fine 
powders with a marble mortar and pestle and carefully formed into a 
10 mm wide thin circular layer on sticky tape. X-ray diffraction patterns 
of the mounted powders were then collected using with a Bruker D5000 
X-ray diffractometer (Bruker ASX, Karlsruhe, Germany) using the Cu 
Ka1 1.5406 Å line, with a 2θ range of 24.6° to 48°, a 0.02° step-size and 
a step time of 0.05 s per° leading to a total scan time of ≈1 h. Detected 
peaks were compared to JCPDS reference patterns to identify the 
crystalline phases in each sample. PDF 00-009-0432 and 00-012-0404 
were used as reference patterns for hydroxyapatite and Whitlockite, 
respectively.
Scanning Electron Microscopy: 12 months-old constructs were fixed 
with 2.5% glutaraldehyde in phosphate buffered saline and dehydrated 
over several steps including immersion in ethanol of increasing 
concentrations and critical point drying using CO2. Samples were coated 
with platinum and SEM images were acquired under vacuum using a 
Philips XL30 FEG ESEM at a resolution of 3 nm at 15 kV. Various cellular 
structures were colored using Adobe Photoshop CC 2015 (Adobe 
Systems Incorporated, CA, USA) to allow a better visualization.
Quantitative Polymerase Chain Reaction: 5 months (n = 4) and 
12 months (n = 2) constructs were removed from culture media 
and the calcium phosphate anchors were cut out of the tissue and 
discarded. Tissues were snap frozen by submersion in liquid nitrogen 
for 1 min, then rapidly pulverized using a multisample biopulverizer 
(BioSpec Products Inc., OK, USA). mRNA extraction was performed 
using a Dynabeads mRNA DirectTM detection kit. The powdered 
tissue extract was lysed using vortex mixing and viscosity of the 
solution was reduced by DNA-shearing with a 21 gauge syringe 
needle. mRNA was isolated with oligo dT superparamagnetic 
beads (Dynabeads) using a Dynabeads MPC-S magnetic particle 
concentrator (Dynal AS Oslo, Norway) and cDNA synthesis was 
performed directly on the bead bound mRNA using a SuperScript 
Reverse Transcriptase kit (Invitrogen, Thermo Fisher Scientific, CA, 
USA). Quantitect primers (Qiagen, Manchester, UK) were used with 
Fast SYBR green master mix (Applied Biosciences, CA, USA) for rat 
podoplanin (QT00174706), sclerostin (QT00418558), glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) (QT00199633), and beta 
actin (QT00193473). Amplification of cDNA was performed using a 
ViiA 7 real-time PCR instrument (Applied Biosystems, CA, USA). As 
positive control, cells from an osteosarcoma cell line positive for 
SOST and PDPN, UMR-106, were used and mRNA was extracted and 
processed in an identical manner. Data were recorded and analyzed 
using the QuantStudio real-time PCR software, version 1.2 2015 
(Applied Biosystems, CA, USA). In addition to no template controls, 
products were validated using melt point analysis to show a single 
high temperature melt point.
Histological Analysis of Whole Constructs: An Alizarin Red dye 
was used to chemically detect the presence of mineralization in 
constructs. Alizarin Red S powder (Sigma-Aldrich, Germany) was 
dissolved in distilled H2O to a concentration of 40 × 10−3 m. The pH 
was adjusted to 4.2 with 10% (v v−1) ammonium hydroxide (Fisher 
Scientific, USA). Constructs were fixed with 10% PFA for 30 min at 
room temperature. Following fixation, the constructs were rinsed 
in phosphate buffered saline solution (Sigma-Aldrich, Germany) to 
remove the excess PFA, and were inserted into 2 mL of Alizarin Red 
solution for 30 min at room temperature. Constructs were rinsed 
three times with PBS to remove unbound dye and were imaged using 
a CETI Inverso TC100 brightfield microscope (Medline Scientific, 
Oxon, United Kingdom) and a Zeiss Axio Lab A1 microscope 
(Carl Zeiss, Jena, Germany).
Sirius Red dye was used to detect collagen synthesis in constructs. 
Sirius Red dye (Direct Red 80, Sigma- Aldrich, Germany) was dissolved 
in saturated aqueous picric acid at a concentration of 1 mg mL−1. 
Constructs were rinsed with PBS and fixed with 2 mL standard Bouin’s 
fluid for 1 h at room temperature. The fixation fluid was aspirated and 
constructs were washed with dH2O for 15 min. 2 mL of dye was added 
per construct and the recipients were placed on a plate shaker for 
1 h (100 RPM). The excess liquid was removed and the unbound dye 
was removed by rinsing with 2 mL 0.01 n hydrochloric acid. Collagen 
deposits were visualized under the microscope.
Histoprocessing: For histology and immunohistochemistry, 
constructs were fixed in 10% neutral buffered formalin for 3 d, and 
were then embedded in paraffin wax blocks for sectioning. 4 µm thick 
paraffin tissue slices were produced using a Leica microtome (Leica 
Microsystems, Wetzlar, Germany).
Glass slides containing tissue sections were deparaffinized and 
rehydrated through subsequent washes with Neo-Clear (xylene 
substitute, Merck Millipore, Massachusetts, USA), twice for 5 min, 100% 
EtOH, 96% EtOH, and 70% EtOH twice for 30 s each time, followed 
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by a 1 min wash with dH2O. Following the application of dyes, slides 
were prepared for long-term storage by washing with dH2O followed 
by dehydration in ascending concentrations of EtOH, as follows: 70%, 
96%, and 100% EtOH twice for 1 min, followed by a final wash with 
Neo-Clear, twice for 5 min. Slides were mounted using a water-free 
agent, Neo-Mount (Merck Millipore, Massachusetts, USA) for long-term 
storage. Tissue sections were imaged using a Leica DM500 microscope 
(Leica Microsystems, Wetzlar, Germany).
H&E Staining of Tissue Sections: A hematoxylin and eosin (H&E) 
stain was used in order to stain cell nuclei, cytoplasm, and the matrix 
of constructs. Hematoxylin staining solution was applied for 3 min and 
slides were washed under running tap water for 3 min. Eosin Y solution 
0.5% was applied for 3 min. Samples were rinsed under running tap 
water for 30 s.
Immunohistological Analysis: Slides containing tissue sections 
were deparaffinized and rehydrated through subsequent washes with 
Neo-Clear (xylene substitute, Merck Millipore, Massachusetts, USA) 
and 100% EtOH twice for 3 min; followed by washes in 95% EtOH, 
70% EtOH, and 50% EtOH for 3 min each time, followed by a wash 
with dH2O. Antigen retrieval was performed using the water-bath 
immersion method, where the slides containing tissue sections were 
immersed in citrate buffer (10 × 10−3 m sodium citrate in dH2O, pH 
6, Abcam, Cambridge, United Kingdom) for 8 h. Slides were washed 
twice for 5 min in tris-buffered saline (TBS), which contained 0.025% 
Triton X-100 (Thermo Fisher Scientific, Massachusetts, USA). Tissue 
sections were blocked in medium containing 1% BSA and 10% normal 
serum in TBS from either donkey or goat, depending on the species 
of the secondary antibodies, for 2 h at room temperature. Primary 
rabbit antibodies against rat sclerostin (Abcam, Cambridge, United 
Kingdom), podoplanin (Abcam, Cambridge, United Kingdom) and 
collagen type I (Col I) (Thermo Fisher Scientific, Massachusetts, USA) 
were diluted to a concentration of 10 µg mL−1 in TBS with 1% BSA. 
Antibodies were applied to the slides and incubation was performed 
overnight at 4 °C. Samples were rinsed twice with TBS containing 
0.025% Triton X-100, with gentle agitation. Secondary antibodies 
(donkey anti-rabbit or goat antirabbit) conjugated to Alexa Fluor 
488 fluorophores, were diluted to 10 µg mL−1 (donkey) or 5 µg mL−1 
(goat) in 1% BSA in TBS and were incubated with the slides for 1 h at 
room temperature. Following incubation, tissue sections were washed 
three times with TBS for 5 min. In order to check for nonspecific 
antibody binding, the steps listed above were performed on additional 
slides, without the addition of the primary antibodies Slides were 
washed with TBS containing 0.1% Triton X-100 for 5 min. Phalloidin 
(Thermo Fisher Scientific, Massachusetts, USA) conjugated to Alexa 
Flor 594 or 555 was used for cytoskeletal labeling. The phallotoxin 
was diluted to a concentration of 200 units per ml (6.6 × 10−6 m) 
and 3U were applied in TBS to each tissue-containing slide. Samples 
were washed with PBS twice. 4′,6-Diamidino-2-phenylindole was 
used for nuclear/DNA staining dissolved in mounting agent. Tissue 
sections were mounted with Pro-Long Diamond anti-fade permanent 
mountant (Thermo Fisher Scientific, Massachusetts, USA) for 
fluorescence preservation. Fluorescence images were acquired using 
an Olympus Fluoview FV1000 confocal laser scanning microscope 
(Olympus, Tokyo, Japan) equipped with a multi-line argon laser FV5-
LAMAR/LAMAR-2 and a Helium–Neon Green Laser FV5-LAHEG-2/
FV5-LAHEG. Images acquired from excitation at 405, 488, and 543 nm 
wavelengths were collected in individual channels and combined 
using the Fluoview FV10-ASW software, version 4.2 (Olympus, Tokyo, 
Japan).
Statistical Analysis: Measurements were acquired in triplicate 
and/or from a sample number of three constructs, unless 
otherwise indicated in the text. Raw data were not preprocessed 
(normalized/transformed) unless indicated otherwise. All data are 
presented as mean ± SD. Statistical analysis was performed using a 
one-tailed distribution t-test, with a heteroscedastic variance assumed. 
A p value lower than 0.05 was chosen for determining significance 
(MS Excel, Washington, USA). Percentage difference was calculated 
using the formula X = (A−B)/A*100.
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